Back to mobile site

Biogen to acquire RayThera for up to $1 billion

June 17, 2026 6:59 PM EDT Send to a Friend
Biogen Inc. (Nasdaq: BIIB) has entered into a definitive agreement to acquire RayThera Inc., a private San Diego-based biotechnology company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login